Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

Hannes Maier; Thomas Lenarz; Parwis Agha-Mir-Salim; Martijn J. H. Agterberg; Andreas Anagiotos; Susan Arndt; Geoffrey Ball; Manohar Bance; Maurizio Barbara; Uwe Baumann; Wolfgang Baumgartner; Daniele Bernardeschi; Dirk Beutner; Arjan Bosman; Robert Briggs; Susan Busch; Marco Caversaccio; Markus Dahm; Ernst Dalhoff; Arnaud Devèze; Azadeh Ebrahimi-Madiseh; Bernard Fraysse; Henning Frenzel; Javier Gavilán; Mohammad Ghoncheh; Bo E. V. Hakansson; William Hodgetts; Myrthe Hol; Julian Holland; Marcus Holmberg; Alexander M. Huber; Herman Jenkins; Roulla Katiri; Kiana Kheirkhah; Assen Koitschev; Martin Kompis; Cris Lanting; Luis Lassaletta; Bob Lerut; Rudolf Leuwer; Thomas Linder; Hubert Löwenheim; Lawrence Lustig; Rishi Mandavia; Manuel Manrique; Jorge Humberto Martins; Griet Mertens; Robert Mlynski; Hamidreza Mojallal; Simonetta Monini; Peter Monksfield; Alexander Müller; Emmanuel Mylanus; Hideko Nakajima; Marcus Neudert; Erwin Offeciers; Flurin Pfiffner; Markus Pietsch; Stefan K. Plontke; Nils Prenzler; Milan Profant; Torsten Rahne; Gunesh Rajan; Anna Ratuszniak; Stefan Raufer; Jaydip Ray; Sabine Reinfeldt; Christof Röösli; Tove Rosenbom; Rolf Salcher; Matthias Schönermark; Burkard Schwab; Henryk Skarżyński; Piotr H. Skarżyński; Hillary Snapp; Georg Sprinzl; Michael Spearman; Stefan Stenfelt; Christof Stieger; Stephane Tringali; Eric Truy; James Tysome; Paul Van de Heyning; Nicolas Verhaert; Thomas Wesarg; Patrik Westerkull; Barbara Wollenberg; Thomas Zahnert; Andrzej Zarowski; Ad Snik

doi:10.1097/MAO.0000000000003491

Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

Hannes Maier, Thomas Lenarz, Parwis Agha-Mir-Salim, Martijn J. H. Agterberg, Andreas Anagiotos, Susan Arndt, Geoffrey Ball, Manohar Bance, Maurizio Barbara, Uwe Baumann, Wolfgang Baumgartner, Daniele Bernardeschi, Dirk Beutner, Arjan Bosman, Robert Briggs, Susan Busch, Marco Caversaccio, Markus Dahm, Ernst Dalhoff, Arnaud DevèzeAzadeh Ebrahimi-Madiseh, Bernard Fraysse, Henning Frenzel, Javier Gavilán, Mohammad Ghoncheh, Bo E. V. Hakansson, William Hodgetts, Myrthe Hol, Julian Holland, Marcus Holmberg, Alexander M. Huber, Herman Jenkins, Roulla Katiri, Kiana Kheirkhah, Assen Koitschev, Martin Kompis, Cris Lanting, Luis Lassaletta, Bob Lerut, Rudolf Leuwer, Thomas Linder, Hubert Löwenheim, Lawrence Lustig, Rishi Mandavia, Manuel Manrique, Jorge Humberto Martins, Griet Mertens, Robert Mlynski, Hamidreza Mojallal, Simonetta Monini, Peter Monksfield, Alexander Müller, Emmanuel Mylanus, Hideko Nakajima, Marcus Neudert, Erwin Offeciers, Flurin Pfiffner, Markus Pietsch, Stefan K. Plontke, Nils Prenzler, Milan Profant, Torsten Rahne, Gunesh Rajan, Anna Ratuszniak, Stefan Raufer, Jaydip Ray, Sabine Reinfeldt, Christof Röösli, Tove Rosenbom, Rolf Salcher, Matthias Schönermark, Burkard Schwab, Henryk Skarżyński, Piotr H. Skarżyński, Hillary Snapp, Georg Sprinzl, Michael Spearman, Stefan Stenfelt, Christof Stieger, Stephane Tringali, Eric Truy, James Tysome, Paul Van de Heyning, Nicolas Verhaert, Thomas Wesarg, Patrik Westerkull, Barbara Wollenberg, Thomas Zahnert, Andrzej Zarowski, Ad Snik

Klinische Abteilung für Hals-Nasen-Ohrenkrankheiten (UK St. Pölten)

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift

33 Zitate (Scopus)

Abstract

ABSTRACT: Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.

Originalsprache	Englisch
Seiten (von - bis)	513-529
Seitenumfang	17
Fachzeitschrift	Otology and Neurotology
Jahrgang	43
Ausgabenummer	5
DOIs	https://doi.org/10.1097/MAO.0000000000003491
Publikationsstatus	Veröffentlicht - 01 Juni 2022

ASJC Scopus Sachgebiete

Klinische Neurologie
Sensorische Systeme
Hals-Nasen-Ohrenheilkunde

Zugriff auf Dokument

10.1097/MAO.0000000000003491

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Maier, H., Lenarz, T., Agha-Mir-Salim, P., Agterberg, M. J. H., Anagiotos, A., Arndt, S., Ball, G., Bance, M., Barbara, M., Baumann, U., Baumgartner, W., Bernardeschi, D., Beutner, D., Bosman, A., Briggs, R., Busch, S., Caversaccio, M., Dahm, M., Dalhoff, E., ... Snik, A. (2022). Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss. Otology and Neurotology, 43(5), 513-529. https://doi.org/10.1097/MAO.0000000000003491

@article{e0cd9e2e1dea4e82ad33bef43e088656,

title = "Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss",

abstract = "ABSTRACT: Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.",

keywords = "Active Active middle ear implants, Auditory system, Bone conduction devices, Consensus statement, Health policy, Mixed hearing loss, Multi-stakeholder approach, Rehabilitation, Surgery, Technical data, Deafness, Reproducibility of Results, Hearing Loss, Conductive/surgery, Humans, Hearing Loss, Mixed Conductive-Sensorineural/surgery, Hearing Aids, Hearing Loss/surgery, Bone Conduction, Ossicular Prosthesis",

author = "Hannes Maier and Thomas Lenarz and Parwis Agha-Mir-Salim and Agterberg, {Martijn J. H.} and Andreas Anagiotos and Susan Arndt and Geoffrey Ball and Manohar Bance and Maurizio Barbara and Uwe Baumann and Wolfgang Baumgartner and Daniele Bernardeschi and Dirk Beutner and Arjan Bosman and Robert Briggs and Susan Busch and Marco Caversaccio and Markus Dahm and Ernst Dalhoff and Arnaud Dev{\`e}ze and Azadeh Ebrahimi-Madiseh and Bernard Fraysse and Henning Frenzel and Javier Gavil{\'a}n and Mohammad Ghoncheh and Hakansson, {Bo E. V.} and William Hodgetts and Myrthe Hol and Julian Holland and Marcus Holmberg and Huber, {Alexander M.} and Herman Jenkins and Roulla Katiri and Kiana Kheirkhah and Assen Koitschev and Martin Kompis and Cris Lanting and Luis Lassaletta and Bob Lerut and Rudolf Leuwer and Thomas Linder and Hubert L{\"o}wenheim and Lawrence Lustig and Rishi Mandavia and Manuel Manrique and Martins, {Jorge Humberto} and Griet Mertens and Robert Mlynski and Hamidreza Mojallal and Simonetta Monini and Peter Monksfield and Alexander M{\"u}ller and Emmanuel Mylanus and Hideko Nakajima and Marcus Neudert and Erwin Offeciers and Flurin Pfiffner and Markus Pietsch and Plontke, {Stefan K.} and Nils Prenzler and Milan Profant and Torsten Rahne and Gunesh Rajan and Anna Ratuszniak and Stefan Raufer and Jaydip Ray and Sabine Reinfeldt and Christof R{\"o}{\"o}sli and Tove Rosenbom and Rolf Salcher and Matthias Sch{\"o}nermark and Burkard Schwab and Henryk Skar{\.z}y{\'n}ski and Skar{\.z}y{\'n}ski, {Piotr H.} and Hillary Snapp and Georg Sprinzl and Michael Spearman and Stefan Stenfelt and Christof Stieger and Stephane Tringali and Eric Truy and James Tysome and {Van de Heyning}, Paul and Nicolas Verhaert and Thomas Wesarg and Patrik Westerkull and Barbara Wollenberg and Thomas Zahnert and Andrzej Zarowski and Ad Snik",

note = "Funding Information: The first meeting on November 4, 2017 for this consensus project was supported by Cochlear Ltd, MED-EL Medical Electronics and Oticon Medical. Publisher Copyright: Copyright {\textcopyright} 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.",

year = "2022",

month = jun,

day = "1",

doi = "10.1097/MAO.0000000000003491",

language = "English",

volume = "43",

pages = "513--529",

journal = "Otology and Neurotology",

issn = "1531-7129",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

Maier, H, Lenarz, T, Agha-Mir-Salim, P, Agterberg, MJH, Anagiotos, A, Arndt, S, Ball, G, Bance, M, Barbara, M, Baumann, U, Baumgartner, W, Bernardeschi, D, Beutner, D, Bosman, A, Briggs, R, Busch, S, Caversaccio, M, Dahm, M, Dalhoff, E, Devèze, A, Ebrahimi-Madiseh, A, Fraysse, B, Frenzel, H, Gavilán, J, Ghoncheh, M, Hakansson, BEV, Hodgetts, W, Hol, M, Holland, J, Holmberg, M, Huber, AM, Jenkins, H, Katiri, R, Kheirkhah, K, Koitschev, A, Kompis, M, Lanting, C, Lassaletta, L, Lerut, B, Leuwer, R, Linder, T, Löwenheim, H, Lustig, L, Mandavia, R, Manrique, M, Martins, JH, Mertens, G, Mlynski, R, Mojallal, H, Monini, S, Monksfield, P, Müller, A, Mylanus, E, Nakajima, H, Neudert, M, Offeciers, E, Pfiffner, F, Pietsch, M, Plontke, SK, Prenzler, N, Profant, M, Rahne, T, Rajan, G, Ratuszniak, A, Raufer, S, Ray, J, Reinfeldt, S, Röösli, C, Rosenbom, T, Salcher, R, Schönermark, M, Schwab, B, Skarżyński, H, Skarżyński, PH, Snapp, H, Sprinzl, G, Spearman, M, Stenfelt, S, Stieger, C, Tringali, S, Truy, E, Tysome, J, Van de Heyning, P, Verhaert, N, Wesarg, T, Westerkull, P, Wollenberg, B, Zahnert, T, Zarowski, A & Snik, A 2022, 'Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss', Otology and Neurotology, Jg. 43, Nr. 5, S. 513-529. https://doi.org/10.1097/MAO.0000000000003491

TY - JOUR

T1 - Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

AU - Maier, Hannes

AU - Lenarz, Thomas

AU - Agha-Mir-Salim, Parwis

AU - Agterberg, Martijn J. H.

AU - Anagiotos, Andreas

AU - Arndt, Susan

AU - Ball, Geoffrey

AU - Bance, Manohar

AU - Barbara, Maurizio

AU - Baumann, Uwe

AU - Baumgartner, Wolfgang

AU - Bernardeschi, Daniele

AU - Beutner, Dirk

AU - Bosman, Arjan

AU - Briggs, Robert

AU - Busch, Susan

AU - Caversaccio, Marco

AU - Dahm, Markus

AU - Dalhoff, Ernst

AU - Devèze, Arnaud

AU - Ebrahimi-Madiseh, Azadeh

AU - Fraysse, Bernard

AU - Frenzel, Henning

AU - Gavilán, Javier

AU - Ghoncheh, Mohammad

AU - Hakansson, Bo E. V.

AU - Hodgetts, William

AU - Hol, Myrthe

AU - Holland, Julian

AU - Holmberg, Marcus

AU - Huber, Alexander M.

AU - Jenkins, Herman

AU - Katiri, Roulla

AU - Kheirkhah, Kiana

AU - Koitschev, Assen

AU - Kompis, Martin

AU - Lanting, Cris

AU - Lassaletta, Luis

AU - Lerut, Bob

AU - Leuwer, Rudolf

AU - Linder, Thomas

AU - Löwenheim, Hubert

AU - Lustig, Lawrence

AU - Mandavia, Rishi

AU - Manrique, Manuel

AU - Martins, Jorge Humberto

AU - Mertens, Griet

AU - Mlynski, Robert

AU - Mojallal, Hamidreza

AU - Monini, Simonetta

AU - Monksfield, Peter

AU - Müller, Alexander

AU - Mylanus, Emmanuel

AU - Nakajima, Hideko

AU - Neudert, Marcus

AU - Offeciers, Erwin

AU - Pfiffner, Flurin

AU - Pietsch, Markus

AU - Plontke, Stefan K.

AU - Prenzler, Nils

AU - Profant, Milan

AU - Rahne, Torsten

AU - Rajan, Gunesh

AU - Ratuszniak, Anna

AU - Raufer, Stefan

AU - Ray, Jaydip

AU - Reinfeldt, Sabine

AU - Röösli, Christof

AU - Rosenbom, Tove

AU - Salcher, Rolf

AU - Schönermark, Matthias

AU - Schwab, Burkard

AU - Skarżyński, Henryk

AU - Skarżyński, Piotr H.

AU - Snapp, Hillary

AU - Sprinzl, Georg

AU - Spearman, Michael

AU - Stenfelt, Stefan

AU - Stieger, Christof

AU - Tringali, Stephane

AU - Truy, Eric

AU - Tysome, James

AU - Van de Heyning, Paul

AU - Verhaert, Nicolas

AU - Wesarg, Thomas

AU - Westerkull, Patrik

AU - Wollenberg, Barbara

AU - Zahnert, Thomas

AU - Zarowski, Andrzej

AU - Snik, Ad

N1 - Funding Information: The first meeting on November 4, 2017 for this consensus project was supported by Cochlear Ltd, MED-EL Medical Electronics and Oticon Medical. Publisher Copyright: Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.

PY - 2022/6/1

Y1 - 2022/6/1

N2 - ABSTRACT: Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.

AB - ABSTRACT: Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.

KW - Active Active middle ear implants

KW - Auditory system

KW - Bone conduction devices

KW - Consensus statement

KW - Health policy

KW - Mixed hearing loss

KW - Multi-stakeholder approach

KW - Rehabilitation

KW - Surgery

KW - Technical data

KW - Deafness

KW - Reproducibility of Results

KW - Hearing Loss, Conductive/surgery

KW - Humans

KW - Hearing Loss, Mixed Conductive-Sensorineural/surgery

KW - Hearing Aids

KW - Hearing Loss/surgery

KW - Bone Conduction

KW - Ossicular Prosthesis

UR - http://www.scopus.com/inward/record.url?scp=85130820395&partnerID=8YFLogxK

U2 - 10.1097/MAO.0000000000003491

DO - 10.1097/MAO.0000000000003491

M3 - Journal article

C2 - 35383700

SN - 1531-7129

VL - 43

SP - 513

EP - 529

JO - Otology and Neurotology

JF - Otology and Neurotology

IS - 5

ER -

Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

Abstract

ASJC Scopus Sachgebiete

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Dieses zitieren